- Home
- RYOJ vs UG Comparison
RYOJ vs UG Comparison
Compare RYOJ & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYOJ
- UG
- Stock Information
- Founded
- RYOJ 2015
- UG 1942
- Country
- RYOJ Japan
- UG United States
- Employees
- RYOJ N/A
- UG N/A
- Industry
- RYOJ Professional Services
- UG Package Goods/Cosmetics
- Sector
- RYOJ Consumer Discretionary
- UG Consumer Discretionary
- Exchange
- RYOJ Nasdaq
- UG Nasdaq
- Market Cap
- RYOJ 32.5M
- UG 36.1M
- IPO Year
- RYOJ 2025
- UG N/A
- Fundamental
- Price
- RYOJ N/A
- UG $7.81
- Analyst Decision
- RYOJ
- UG
- Analyst Count
- RYOJ 0
- UG 0
- Target Price
- RYOJ N/A
- UG N/A
- AVG Volume (30 Days)
- RYOJ 348.0K
- UG 10.2K
- Earning Date
- RYOJ 01-01-0001
- UG 08-08-2025
- Dividend Yield
- RYOJ N/A
- UG 8.95%
- EPS Growth
- RYOJ 72.91
- UG N/A
- EPS
- RYOJ 0.13
- UG 0.56
- Revenue
- RYOJ $11,576,848.00
- UG $10,856,174.00
- Revenue This Year
- RYOJ N/A
- UG N/A
- Revenue Next Year
- RYOJ N/A
- UG N/A
- P/E Ratio
- RYOJ $21.69
- UG $14.14
- Revenue Growth
- RYOJ 5.60
- UG N/A
- 52 Week Low
- RYOJ $2.41
- UG $7.73
- 52 Week High
- RYOJ $3.75
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- RYOJ N/A
- UG 39.20
- Support Level
- RYOJ N/A
- UG $7.80
- Resistance Level
- RYOJ N/A
- UG $8.23
- Average True Range (ATR)
- RYOJ 0.00
- UG 0.28
- MACD
- RYOJ 0.00
- UG -0.03
- Stochastic Oscillator
- RYOJ 0.00
- UG 1.45
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.